1. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.
- Author
-
Aby, Elizabeth S, Moafa, Ghady, Latt, Nyan, Sultan, Mohammad T, Cacioppo, Paula A, Kumar, Sonal, Chung, Raymond T, Bloom, Patricia P, Gustafson, Jenna, Daidone, Michael, Reinus, Zoe, Debes, Jose D, Sandhu, Sunny, Sohal, Aalam, Khalid, Sameeha, Roytman, Marina, Catana, Andreea Maria, Wegermann, Kara, Carr, Rotonya M, Saiman, Yedidya, Kassab, Ihab, Chen, Vincent L, Rabiee, Atoosa, Rosenberg, Carly, Nguyen, Veronica, Gainey, Christina, Zhou, Kali, Chavin, Kenneth, Lizaola-Mayo, Blanca C, Chascsa, David M, Varelas, Lee, Moghe, Akshata, and Dhanasekaran, Renumathy
- Subjects
Humans ,Liver Diseases ,Hospitalization ,Adult ,Middle Aged ,Female ,Male ,COVID-19 ,COVID-19 Vaccines ,Post-Acute COVID-19 Syndrome ,Digestive Diseases ,Vaccine Related ,Liver Disease ,Clinical Research ,Management of diseases and conditions ,7.1 Individual care needs ,Good Health and Well Being - Abstract
BackgroundCOVID-19 is associated with higher morbidity and mortality in patients with chronic liver diseases (CLDs). However, our understanding of the long-term outcomes of COVID-19 in patients with CLD is limited.MethodsWe conducted a multicenter, observational cohort study of adult patients with CLD who were diagnosed with COVID-19 before May 30, 2020, to determine long-term clinical outcomes. We used a control group of patients with CLD confirmed negative for COVID-19.ResultsWe followed 666 patients with CLD (median age 58 years, 52.8% male) for a median of 384 (interquartile range: 31-462) days. The long-term mortality was 8.1%; with 3.6% experiencing delayed COVID-19-related mortality. Compared to a propensity-matched control group of patients with CLD without COVID-19 (n=1332), patients with CLD with COVID-19 had worse long-term survival [p
- Published
- 2023